Skip to main navigation

About Us
- Leadership
- Board of Directors
Science
- About CNM-Au8®
Pipeline
Patients
- EAP
Investors
Contact

About Us
- Leadership
- Board of Directors
Science
- About CNM-Au8®
Pipeline
Patients
- EAP
Investors
Contact

News

Year

CNM-Au8 preserves white matter in RRMS patients’ brains: Phase 2 trial

Multiple Sclerosis News Today

February 14, 2023

MRI data boost Clene energy metabolism hypothesis; phase III ahead

BioWorld

February 13, 2023

MRI Data Reinforce Potential of Clene’s Nanocrystal Therapy in MS

BioSpace

February 13, 2023

Pagination

First page
Previous page
Page 1
Current page 2

1-801-676-9695
info@CleneNanomedicine.com
@CleneNano

Headquarters and Development

6550 South Millrock Drive, Suite G50
Salt Lake City, Utah 84121

Manufacturing, R&D

500 Principio Parkway West Suite 400
North East, Maryland 21901

Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2023 Clene Nanomedicine, Inc. - All rights reserved